Odyssey Health (ODYY) Net Income towards Common Stockholders Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Odyssey Health | - | - | - | -170.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -170.01% |
| Oct 31, 2025 | 38.52% |
| Jul 31, 2025 | 98.02% |
| Apr 30, 2025 | 70.11% |
| Jan 31, 2025 | -101.67% |
| Oct 31, 2024 | -20.46% |
| Jul 31, 2024 | -1,465.03% |
| Apr 30, 2024 | 34.40% |
| Jan 31, 2024 | 890.45% |
| Oct 31, 2023 | 74.96% |
| Jul 31, 2023 | 59.55% |
| Apr 30, 2023 | 58.57% |
| Jan 31, 2023 | 23.48% |
| Oct 31, 2022 | -30.54% |
| Jul 31, 2022 | 30.61% |
| Apr 30, 2022 | 75.11% |
| Jan 31, 2022 | -151.32% |
| Oct 31, 2021 | -131.38% |
| Jul 31, 2021 | -117.76% |
| Apr 30, 2021 | -1,146.07% |
| Jan 31, 2021 | -44.66% |
| Oct 31, 2020 | 49.77% |
| Jul 31, 2020 | 94.31% |
| Apr 30, 2020 | -1,491.99% |
| Jan 31, 2020 | -464.42% |
| Oct 31, 2019 | -1,938.41% |
| Jul 31, 2019 | -23,570.87% |
| Apr 30, 2019 | 14.68% |
| Jan 31, 2019 | 56.94% |
| Oct 31, 2018 | -9.60% |
| Jul 31, 2018 | -52.65% |
| Apr 30, 2018 | 8.06% |
| Jan 31, 2018 | -693.13% |
| Oct 31, 2017 | -189.93% |
| Jul 31, 2017 | -75.89% |
| Apr 30, 2017 | -877.66% |
| Jan 31, 2017 | -93.57% |
| Oct 31, 2016 | 12.50% |
| Jul 31, 2016 | -53.11% |
| Apr 30, 2016 | 80.74% |
| Jan 31, 2016 | 68.21% |
| Oct 31, 2015 | 42.51% |